IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
KMS Medisurgi IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 2.70 Cr. The company is based in Mumbai and caters to Healthcare sector. Navigant Corporate Advisors is the merchant banker of KMS Medisurgi IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th September 2016.
KMS Medisurgi IPO posted revenues of ₹ 7.60 crores and PAT of ₹ 0.19 crores in FY17 on annualised basis.
Revenue:
₹ 7.48 Cr.
EBITDA Margin:
13.01
% 
Net Worth: ₹ 3.46 Cr.
Market Capitalisation:
[●]
P/E:
60.00 times
P/BV: [●]
EV/EBITDA: 1.07 times
Financial results of KMS Medisurgi IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Dec-16 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 8.23 | 8.05 | 7.20 | 7.01 | |
| Net Worth | 3.46 | 3.32 | 1.13 | 1.11 | |
| Total Debt | 2.36 | 2.12 | 2.84 | 3.97 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
5.61
7.48 |
8.41 | 8.89 | 7.61 | |
EBITDA
EBITDA on annualised basis |
0.73
0.97 |
0.87 | 0.75 | 0.66 | |
PAT
PAT on annualised basis |
0.14
0.19 |
0.14 | 0.03 | 0.03 | |
KMS Medisurgi IPO PAT Margin is 2.50 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows KMS Medisurgi IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Dec-16 | FY16 | FY15 | FY14 |
|---|---|---|---|---|
| EBITDA Margin (%) | 13.01 | 10.34 | 8.44 | 8.67 |
| PAT Margin (%) | 2.50 | 1.66 | 0.34 | 0.39 |
| EPS (₹) | 0.58 | 2.72 | 0.63 | 0.54 |
| ROE (%) | 4.05 | 4.22 | 2.65 | 2.70 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 1.70 | 1.74 | 0.42 | 0.43 |
| Debt to Equity | 0.68 | 0.64 | 2.51 | 3.58 |
The market Capitalisation of KMS Medisurgi IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The KMS Medisurgi IPO prospectus highlights an Return on Equity (ROE) of 4.05 % , Return on Assets (ROA) of 1.70 %, and an EBITDA Margin of 13.01 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows KMS Medisurgi IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of KMS Medisurgi IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The KMS Medisurgi IPO has a Price-to-Earnings (PE) ratio of 60.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
KMS Medisurgi IPO reported revenue of ₹ 7.60 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from KMS Medisurgi IPO provide insights into sales growth, market demand, and business scalability.
KMS Medisurgi recorded an EBITDA of ₹ 0.97 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
KMS Medisurgi Profit After Tax (PAT) is ₹ 0.19 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 7.48 Cr.
EBITDA Margin:
13.01
%
Net Worth: ₹ 3.46 Cr.
Market Capitalisation:
[●]
P/E:
60.00 times
P/BV: [●]
EV/EBITDA: 1.07 times
KMS Medisurgi operates in Healthcare and Equipment And Medical Services. The Issue is listed on BSE SME in Apr, 2017. KMS Medisurgi IPO size was 2.70 with Issue price of 30.00 .
Merchant Banker(s) of KMS Medisurgi IPO: Navigant Corporate Advisors Limited
KMS Medisurgi IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
KMS Medisurgi IPO listed at a listing price of 30.50 against the offer price of 30.00.
The current market price of KMS Medisurgi is 126.90.
Why Us?
